Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00015301 · ClinicalTrials.gov registry record · Phase 4
Methylphenidate Raclopride Positron Emission Tomography (PET) Test - 11
A Phase 4 study of Substance-Related Disorders and Cocaine-Related Disorders, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 4
- Development phase
- 1
- Study location
NCT00015301: Completed Phase 4 study of Substance-Related Disorders and Cocaine-Related Disorders, sponsored by National Institute on Drug Abuse (NIDA).
NCT00015301 is a Phase 4 study of Substance-Related Disorders and Cocaine-Related Disorders that has completed, run by National Institute on Drug Abuse (NIDA). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00015301, a Phase 4 study of Substance-Related Disorders and Cocaine-Related Disorders, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 1
- Study location
Study Summary
The purpose of this study is to evaluate PET methodology to study in vivo synaptic dopamine release.
Conditions Studied
Interventions
- DRUG Methylphenidate
Study Locations (1)
New York
- New York MDRU - New York
Trial Details
| Field | Value |
|---|---|
| Start Date | 2003-12 |
| Est. Completion | 2005-08 |
| Phase | Phase 4 |
What the finished NCT00015301 record still lists
NCT00015301 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 2 conditions, with Substance-Related Disorders appearing as the primary indexed condition, and to 1 intervention - of which Methylphenidate is the first listed.
NCT00015301 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00015301 about?
NCT00015301 is a clinical study titled "Methylphenidate Raclopride Positron Emission Tomography (PET) Test - 11". The purpose of this study is to evaluate PET methodology to study in vivo synaptic dopamine release.
What is the current status of trial NCT00015301?
This trial is currently completed. It is a Phase 4 study. The study started on 2003-12. Estimated completion is 2005-08.
What conditions does trial NCT00015301 study?
This clinical trial studies the following conditions: Substance-Related Disorders, Cocaine-Related Disorders.
What interventions are being tested in trial NCT00015301?
The interventions under investigation include: Methylphenidate (DRUG).
Who is sponsoring clinical trial NCT00015301?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00015301 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance-Related Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Modeling Impaired Judgement in Cocaine Abusers - 6
COMPLETED · Phase 4
-
Quetiapine for Cocaine Use and Cravings
COMPLETED · Phase 4
-
Relapse Prevention With Varenicline
COMPLETED · Phase 4
-
Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14
COMPLETED · Phase 4
-
Buprenorphine and Integrated HIV Care
COMPLETED · Phase 4
-
Integration of Buprenorphine Into HIV Clinical Settings - Primary Care Model (PCM)
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia